Source: Global Legal Chronicle

HiFiBiO: FibroGen's Partnership with HiFiBiO Therapeutics

Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune [...]

Read full article »
HiFiBiO's Competitors | HiFiBiO's News | HiFiBiO's Financials
Stay up-to-date with the latest news on HiFiBiO
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Liang Schweizer's photo - Chairman & CEO of HiFiBiO

Chairman & CEO

Liang Schweizer

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on HiFiBiO